DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1Dr. Reddy's Laboratories Ltd.
02 1Cohance Life Sciences Limited
03 1Cheer Fine Pharmaceutical Co. , Ltd.
04 1DONGBANG FUTURE TECH & LIFE CO. , LTD.
05 1Jiangxi Synergy Pharmaceutical Co. , Ltd.
06 1Sanyo Chemical Research Institute Co., Ltd.
07 1Sumitomo Chemical Co., Ltd.
Reset all filters
01 7Rivaroxaban
Reset all filters
01 2China
02 1Gabon
03 2India
04 1Japan
05 1South Korea
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registration Number : 304MF10061
Registrant's Address : 8-2-337, Road No. 3, Banjara Hills, Hyderabad 500 034, TELANGANA, INDIA
Initial Date of Registration : 2022-04-06
Latest Date of Registration : 2022-04-06
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Registration Number : 304MF10154
Registrant's Address : 215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala MIDC, Chakala, An...
Initial Date of Registration : 2022-12-07
Latest Date of Registration : 2022-12-07
Registration Number : 303MF10082
Registrant's Address : No. 2066 Tangkou Road, Economy and Technology Development Zone, Hefei, Anhui Province...
Initial Date of Registration : 2021-05-27
Latest Date of Registration : 2021-05-27
Registration Number : 302MF10079
Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea
Initial Date of Registration : 2020-07-09
Latest Date of Registration : 2024-05-15
Registration Number : 304MF10027
Registrant's Address : Jiangxi Fengxin Industrial Park, Fengxin, 330700, Jiangxi Province, P. R. China
Initial Date of Registration : 2022-02-10
Latest Date of Registration : 2022-02-10
Registration Number : 304MF10101
Registrant's Address : 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Initial Date of Registration : 2022-07-13
Latest Date of Registration : 2022-07-13
Registration Number : 303MF10102
Registrant's Address : 148-1 Tajii, Mihara-ku, Sakai City, Osaka Prefecture
Initial Date of Registration : 2021-07-06
Latest Date of Registration : 2021-07-06
79
PharmaCompass offers a list of Rivaroxaban API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rivaroxaban manufacturer or Rivaroxaban supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rivaroxaban manufacturer or Rivaroxaban supplier.
PharmaCompass also assists you with knowing the Rivaroxaban API Price utilized in the formulation of products. Rivaroxaban API Price is not always fixed or binding as the Rivaroxaban Price is obtained through a variety of data sources. The Rivaroxaban Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Xarelto manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Xarelto, including repackagers and relabelers. The FDA regulates Xarelto manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Xarelto API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Xarelto manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Xarelto supplier is an individual or a company that provides Xarelto active pharmaceutical ingredient (API) or Xarelto finished formulations upon request. The Xarelto suppliers may include Xarelto API manufacturers, exporters, distributors and traders.
click here to find a list of Xarelto suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Xarelto Drug Master File in Japan (Xarelto JDMF) empowers Xarelto API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Xarelto JDMF during the approval evaluation for pharmaceutical products. At the time of Xarelto JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Xarelto suppliers with JDMF on PharmaCompass.
We have 6 companies offering Xarelto
Get in contact with the supplier of your choice: